EDITORIAL
Published on 11 Dec 2024
Editorial: Advances in targeted therapy and biomarker research for endocrine-related cancers
doi 10.3389/fendo.2024.1533623
- 251 views
- Frontiers in Endocrinology
- Cancer Endocrinology
- Research Topics
- Advances in Targeted Therapy and Biomarker Research for Endocrine-Related Cancers
Advances in Targeted Therapy and Biomarker Research for Endocrine-Related Cancers
7,027
Total downloads
22k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 15 Nov 2024
Functional analysis of fibroblasts and macrophages in head and neck paragangliomas
doi 10.3389/fendo.2024.1397839
- 588 views
REVIEW
Published on 31 Oct 2024
Mechanisms of endocrine resistance in hormone receptor-positive breast cancer
doi 10.3389/fonc.2024.1448687
- 841 views
MINI REVIEW
Published on 08 Oct 2024
Unveiling new chapters in medullary thyroid carcinoma therapy: advances in molecular genetics and targeted treatment strategies
doi 10.3389/fendo.2024.1484815
- 954 views
ORIGINAL RESEARCH
Published on 16 Sep 2024
Identifying new biomarkers and potential therapeutic targets for breast cancer through the integration of human plasma proteomics: a Mendelian randomization study and colocalization analysis
doi 10.3389/fendo.2024.1449668
- 1,512 views
SYSTEMATIC REVIEW
Published on 29 Aug 2024
The prognostic value of preoperative plasma fibrinogen in Asian patients with urothelial cancer: a systematic review and meta-analysis
doi 10.3389/fendo.2024.1360595
- 382 views
ORIGINAL RESEARCH
Published on 07 Aug 2024
A nomogram based on inflammation and nutritional biomarkers for predicting the survival of breast cancer patients
doi 10.3389/fendo.2024.1388861
- 657 views
ORIGINAL RESEARCH
Published on 10 Jul 2024
Exploring the multifaceted antitumor activity of axitinib in lung carcinoids
doi 10.3389/fendo.2024.1433707
- 761 views
ORIGINAL RESEARCH
Published on 27 Jun 2024
What are the needs in oral antitumor therapy? An analysis of patients’ and practitioners’ preferences
doi 10.3389/fonc.2024.1388087
- 1,301 views
ORIGINAL RESEARCH
Published on 18 Jun 2024
Is the percentage of hormone receptor positivity in HR+ HER2-metastatic breast cancer patients receiving CDK 4/6 inhibitor with endocrine therapy predictive and prognostic?
doi 10.3389/fonc.2024.1378563
- 1,088 views
METHODS
Published on 31 May 2024
Cathepsins and cancer risk: a Mendelian randomization study
doi 10.3389/fendo.2024.1428433
- 2,405 views
- 1 citation
ORIGINAL RESEARCH
Published on 22 May 2024
Causal associations between platelet count, alcohol consumption, and the risk of liver hepatocellular carcinoma based on a Mendelian randomization study
doi 10.3389/fendo.2024.1400573
- 1,695 views
Published in
Frontiers in Endocrinology
- Cancer Endocrinology
Impact
- 22kTopic views
- 13kArticle views
- 7,027Article downloads